DocSym
β
Searchsearch
Search
(Y46) Antiepileptics and antiparkinsonism drugs
More details coming soon
24 262 in individuals diagnosis antiepileptics and antiparkinsonism drugs confirmed
2 651 deaths with diagnosis antiepileptics and antiparkinsonism drugs
11% mortality rate associated with the disease antiepileptics and antiparkinsonism drugs
Diagnosis antiepileptics and antiparkinsonism drugs is diagnosed Women are 27.64% more likely than Men
8 778
Men receive the diagnosis antiepileptics and antiparkinsonism drugs
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
15 484
Women receive the diagnosis antiepileptics and antiparkinsonism drugs
2 651 (17.1 %)Died from this diagnosis.
Risk Group for the Disease antiepileptics and antiparkinsonism drugs - Men aged 25-29 and Women aged 60-64
In Men diagnosis is most often set at age 0-5, 25-39, 50-59, 70-74
Less common in men the disease occurs at Age 0-1, 5-24, 40-49, 60-69, 75-95+Less common in women the disease occurs at Age 0-1, 5-34, 45-49, 85-95+
In Women diagnosis is most often set at age 0-5, 35-44, 50-84
Disease Features antiepileptics and antiparkinsonism drugs
Absence or low individual and public risk
Antiepileptics and antiparkinsonism drugs - what does this mean
Antiepileptic and antiparkinsonism drugs are used to treat seizures and parkinson's disease, respectively. seizures are caused by abnormal electrical activity in the brain, while parkinson's disease is caused by a lack of dopamine in the brain. both conditions can be managed with medications that reduce the intensity of the symptoms. antiepileptic drugs work by reducing the amount of electrical activity in the brain, while antiparkinsonism drugs increase the amount of dopamine in the brain.
What happens during the disease - antiepileptics and antiparkinsonism drugs
Antiepileptics and antiparkinsonism drugs work by blocking the release of certain neurotransmitters, such as dopamine, in the brain. this helps to reduce the frequency and severity of seizures and parkinson's symptoms. by blocking the release of these neurotransmitters, the drugs can help to reduce the excitability of neurons, which can help to control seizures and other symptoms associated with parkinson's disease.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Neurological examination
- Imaging tests such as MRI or CT scan
- Electroencephalogram (EEG) test
- Urine and stool tests
- Genetic testing
- Lumbar puncture (spinal tap)
- Drug screening
Treatment and Medical Assistance
Main goal of the treatment: To reduce the symptoms of antiepileptics and antiparkinsonism drugs.
- Prescribing antiepileptics and antiparkinsonism drugs
- Regular monitoring of drug therapy
- Educating patients on the importance of taking medication as prescribed
- Assessing patients for any side effects
- Providing lifestyle advice and support
- Referring patients to other specialists for additional support
- Encouraging patients to participate in physical activities and exercise
- Encouraging patients to maintain a healthy diet
- Discussing alternative therapies such as cognitive behavioural therapy (CBT)
13 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Antiepileptics and antiparkinsonism drugs - Prevention
The primary prevention of antiepileptics and antiparkinsonism drugs is to identify and manage the underlying cause of the condition, such as identifying and treating any underlying medical conditions that may be causing the seizures or parkinsonism. additionally, lifestyle modifications, such as avoiding triggers that may lead to seizures or parkinsonism, and taking regular medications as prescribed by a doctor, can help to prevent the need for antiepileptics and antiparkinsonism drugs.